XML 143 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Operating assets and liabilities - Intangible assets and property, plant and equipment - Intangible assets - Narrative (Details)
kr in Millions, $ in Millions
12 Months Ended
Dec. 31, 2020
DKK (kr)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
DKK (kr)
Dec. 31, 2018
DKK (kr)
Disclosure of detailed information about intangible assets [line items]        
Purchase of intangible assets, classified as investing activities kr 16,256   kr 2,299 kr 2,774
Intangible assets 20,657   5,835  
Total impairment losses 350   982 0
Impairment loss recognised in cost of goods sold intangible assets other than goodwill     529  
Impairment loss recognised in research and development intangible assets other than goodwill     450  
Gross carrying amount        
Disclosure of detailed information about intangible assets [line items]        
Additions during the year 16,302   2,179  
Intangible assets kr 25,340   9,830 7,659
Emisphere        
Disclosure of detailed information about intangible assets [line items]        
Purchase of intangible assets, classified as investing activities | $   $ 1,335    
Remaining amortisation period of intangible assets material to entity 14 years 14 years    
Emisphere | Gross carrying amount        
Disclosure of detailed information about intangible assets [line items]        
Intangible assets kr 7,716      
MHR Fund Management        
Disclosure of detailed information about intangible assets [line items]        
Purchase of intangible assets, classified as investing activities | $   $ 450    
Internally generated        
Disclosure of detailed information about intangible assets [line items]        
Additions during the year 396   221  
Corvidia Therapeutics, Inc., United States        
Disclosure of detailed information about intangible assets [line items]        
Increase (decrease) in intangible assets other than goodwill 4,580      
Patents and licences        
Disclosure of detailed information about intangible assets [line items]        
Intangible assets 19,269   4,627  
Total impairment losses 350   982  
Intangible assets not yet in use 9,607   3,380  
Patents and licences | Gross carrying amount        
Disclosure of detailed information about intangible assets [line items]        
Additions during the year 15,906   1,958  
Intangible assets 22,404   7,270 kr 5,247
Patents and licences | Emisphere        
Disclosure of detailed information about intangible assets [line items]        
Additions during the year 11,060      
Additions other than through Business Combinations, Intangible Assets other than Goodwill, not yet in use kr 2,467      
Patents and licences | Top of range        
Disclosure of detailed information about intangible assets [line items]        
Useful life 15 years 15 years    
Computer software | Bottom of range        
Disclosure of detailed information about intangible assets [line items]        
Useful life 3 years 3 years    
Computer software | Top of range        
Disclosure of detailed information about intangible assets [line items]        
Useful life 15 years 15 years    
Diabetes and Obesity care        
Disclosure of detailed information about intangible assets [line items]        
Total impairment losses kr 350   282  
Biopharm        
Disclosure of detailed information about intangible assets [line items]        
Total impairment losses     kr 700